Published in Int J Cancer on June 15, 1988
The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up. Br J Cancer (1989) 1.55
Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer (2000) 1.35
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer (1998) 1.28
DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer (1990) 1.21
Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer (1996) 1.19
Flow cytometric DNA measurement and cytomorphometric analysis of formalin fixed rat mammary tumours. Br J Cancer (1991) 0.76
Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy. Br J Cancer (1992) 0.76
Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med (1998) 6.09
Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg (1993) 4.24
Approaching equity in consumer health information delivery: NetWellness. J Am Med Inform Assoc (1997) 2.80
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J (2005) 2.60
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst (1996) 2.51
The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Respir Med (2008) 2.21
Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer (1999) 2.20
Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int (1999) 2.17
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med (1991) 2.09
Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem (1986) 2.05
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology (1998) 1.96
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol (2005) 1.89
Synthesis in vitro of keratin polypeptides directed by mRNA isolated from newborn and adult mouse epidermis. Eur J Biochem (1980) 1.84
Endocrine treatment options for advanced breast cancer--the role of fulvestrant. Eur J Cancer (2005) 1.65
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
BioMiner--modeling, analyzing, and visualizing biochemical pathways and networks. Bioinformatics (2002) 1.55
Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations. Forensic Sci Int (2010) 1.55
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. Ann Oncol (2003) 1.53
Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J (1983) 1.50
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin. J Natl Cancer Inst (1982) 1.49
Cytokine release from placental endothelial cells, a process associated with preterm labour in the absence of intrauterine infection. Cytokine (1999) 1.44
Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res (1983) 1.42
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res (1997) 1.42
Nitrous oxide is a potent cerebrovasodilator in humans when added to isoflurane. A transcranial Doppler study. Acta Anaesthesiol Scand (1995) 1.40
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study. Int J Radiat Oncol Biol Phys (2000) 1.37
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol (1992) 1.32
Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci U S A (1983) 1.28
Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol (1998) 1.27
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study. Ann Oncol (2010) 1.27
Characteristics of stimulation of H+ transport by aldosterone in turtle urinary bladder. J Clin Invest (1976) 1.24
CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax (2001) 1.24
Augmentation of mechanical properties in osteoporotic vertebral bones--a biomechanical investigation of vertebroplasty efficacy with different bone cements. Eur Spine J (2001) 1.24
Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene (2006) 1.24
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms. Respir Med (2010) 1.23
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe Frauenheilkd (1994) 1.22
Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol (1998) 1.22
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. Ann Oncol (2007) 1.22
Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med (1997) 1.21
HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia (2005) 1.21
Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer (1995) 1.20
Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res (1994) 1.19
Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol (1988) 1.19
The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics (1991) 1.19
Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1992) 1.17
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer. Breast Cancer Res Treat (2008) 1.17
Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J Immunol (2000) 1.17
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes. Nucleic Acids Res (1999) 1.16
[Therapeutic indications: on the concept and applications]. Med Klin (Munich) (1996) 1.14
Home-care vs. institutional rehabilitation of stroke: a comparative study. Mo Med (1966) 1.13
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy. J Clin Pathol (2007) 1.13
The anaesthesia critical incident reporting system: an experience based database. Int J Med Inform (1997) 1.12
[The morphology of the epidermal-dermal junction in the NMRI-mouse during the hair-cycle]. Z Krebsforsch (1970) 1.12
Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women. Eur J Obstet Gynecol Reprod Biol (1983) 1.12
Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin. J Immunol (1998) 1.11
CRITLEVEL: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inf Med (1984) 1.11
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer (1995) 1.11
FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol (1994) 1.11
Rational combinations of siRNAs targeting Plk1 with breast cancer drugs. Oncogene (2007) 1.11
Thickness of the stratum corneum of the volar fingertips. Clin Anat (2000) 1.11
Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. Pathol Res Pract (2000) 1.10
Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol (2001) 1.10
Diagnostic and therapeutic pleuroscopy. Experience with 127 patients. Chest (1980) 1.08
Molecular classification of breast cancer patients by gene expression profiling. J Pathol (2001) 1.08
The proliferative index (PI) of human breast cancer as obtained by flow cytometry. Pathol Res Pract (1984) 1.08
Transport of H+ against electrochemical gradients in turtle urinary bladder. Am J Physiol (1977) 1.07
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer. Eur J Cancer (2011) 1.06
Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary. Proc Natl Acad Sci U S A (1981) 1.06
Impact of intrapartum monitoring on perinatal mortality and morbidity. Contrib Gynecol Obstet (1977) 1.05
Keratins as markers of malignancy in mouse epidermal tumors. Carcinogenesis (1980) 1.05
Photoinitiated destabilization of sterically stabilized liposomes. Biochim Biophys Acta (2001) 1.05
B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis (2005) 1.04
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia (2007) 1.03
An electronic consumer health library: NetWellness. Bull Med Libr Assoc (1996) 1.03
Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up. Eur J Cancer (2002) 1.03
Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma. Cancer (1977) 1.02
Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys (1996) 1.00
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. Ann Oncol (2004) 1.00
Clinical characteristics of viral intestinal infection in preterm and term neonates. Eur J Clin Microbiol Infect Dis (2010) 1.00
A model for enhancing worldwide personal health and wellness. Stud Health Technol Inform (1998) 1.00
Repeated dural punctures increase the incidence of postdural puncture headache. Anesth Analg (1996) 0.99
International inter- and intrahospital patient spread of a multiple antibiotic-resistant strain of Klebsiella pneumoniae. J Infect Dis (1995) 0.99
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia (2007) 0.99
Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95). Eur J Immunol (1996) 0.99
Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer. Ann Oncol (2005) 0.99
Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. I. Effects on pyramidal cell activity. Brain Res (1980) 0.98
Fertility preservation in cancer patients. Minerva Ginecol (2010) 0.98